BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12608509)

  • 1. Orexigenic and anabolic agents.
    Morley JE
    Clin Geriatr Med; 2002 Nov; 18(4):853-66. PubMed ID: 12608509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
    Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B
    J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
    J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation.
    Jatoi A; Yamashita J; Sloan JA; Novotny PJ; Windschitl HE; Loprinzi CL
    Support Care Cancer; 2002 Jan; 10(1):71-5. PubMed ID: 11777191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the efficacy of appetite stimulating medications in hospitalized adults.
    Steiner L; Brunetti L; Roberts S; Ziegler J
    Nutr Clin Pract; 2023 Feb; 38(1):80-87. PubMed ID: 35076955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On appetite and its loss.
    Jatoi A; Kumar S; Sloan JA; Nguyen PL
    J Clin Oncol; 2003 May; 21(9 Suppl):79s-81s. PubMed ID: 12743203
    [No Abstract]   [Full Text] [Related]  

  • 7. A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss.
    Bodenner D; Spencer T; Riggs AT; Redman C; Strunk B; Hughes T
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):137-46. PubMed ID: 17719516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss in older persons: new therapeutic approaches.
    Morley JE
    Curr Pharm Des; 2007; 13(35):3637-47. PubMed ID: 18220800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Appetite-Stimulating Medications in the Inpatient Setting.
    Howard ML; Hossaini R; Tolar C; Gaviola ML
    Ann Pharmacother; 2019 Mar; 53(3):261-267. PubMed ID: 30229678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia.
    Von Roenn JH
    Oncology; 1994 Oct; 51 Suppl 1():19-24. PubMed ID: 7970504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anorexia/cachexia in patients with HIV: lessons for the oncologist.
    Von Roenn JH; Knopf K
    Oncology (Williston Park); 1996 Jul; 10(7):1049-56; discussion 1062-4, 1067-8. PubMed ID: 8837121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of dronabinol and megestrol acetate.
    Reynolds R
    J Clin Oncol; 2002 Jun; 20(12):2912-3; author reply 2913. PubMed ID: 12065574
    [No Abstract]   [Full Text] [Related]  

  • 13. Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection.
    Von Roenn JH; Murphy RL; Wegener N
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):13-6. PubMed ID: 2259923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly.
    Fox CB; Treadway AK; Blaszczyk AT; Sleeper RB
    Pharmacotherapy; 2009 Apr; 29(4):383-97. PubMed ID: 19323618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
    Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
    Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity score-matching analysis comparing safety outcomes of appetite-stimulating medications in oncology patients.
    Marie Gavioli E; Burger A; Gamaleldin A; Eladghm N; Vider E
    Support Care Cancer; 2022 Jul; 30(7):6299-6305. PubMed ID: 35471615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
    Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
    Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
    Berenstein EG; Ortiz Z
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
    Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
    J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis.
    Nasr SZ; Hurwitz ME; Brown RW; Elghoroury M; Rosen D
    Pediatr Pulmonol; 1999 Nov; 28(5):380-2. PubMed ID: 10536070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.